Key result
Ultrasound-guided regional anesthesia is advantageous or equivocal compared to traditional nerve stimulation techniques, but has never been proven inferior.
Why the study?
Does ultrasound-guided regional anesthesia improve acute pain-related outcomes compared to traditional nerve stimulation in patients undergoing regional anesthesia?
Does ultrasound-guided regional anesthesia improve acute pain-related outcomes compared to traditional nerve stimulation in patients undergoing regional anesthesia?
Answers are grounded in this paper and cite their sources.
Equivalence between ultrasound-guided and nerve stimulation techniques for acute pain outcomes is a victory as it expands the use of regional anesthesia.
Ultrasound (US) has revolutionized almost every medical discipline.1 The anesthesia community now uses US routinely in the form of transesophageal echocardiography, facilitation of vascular access, and guidance for regional anesthesia. Clearly, US-guided regional anesthesia (UGRA) has increased in popularity. This is evident by the popular expansion of workshops at the American Society of Regional Anesthesia meetings, a designated section of the journal Regional Anesthesia and Pain Medicine, the incorporation of UGRA curriculums in academic training programs, the committed UGRA chapter in Miller's Anesthesia textbook,2 and the plethora of web-based resources. Despite its popular growth, the question remains whether US techniques are superior to traditional landmark techniques incorporating nerve stimulation (NS). The answer to this question depends on the outcome variable being studied as well as the individual definitions of success versus failure. For technical block-related outcomes such as performance time, block onset, local anesthetic dose, and sensory block quality, the literature overall supports the use of UGRA and demonstrates superiority over the traditional nerve localization techniques (i.e., nerve stimulation).3–5 However, US has received its share of criticism.6,7 It has been questioned whether these technical block-related outcomes are clinically meaningful.8 In other words, even if US allowed for the quicker placement of peripheral nerve blocks with a quicker onset time, does this prove overall superiority? Critics would answer “no,” because multiple controlled trials have failed to ultimately demonstrate a US-related reduction in the need for conversion to general anesthesia.9 Therefore, when a successful surgical block specifically defines the quality metric, US seems to represent a nonbeneficial additional cost in comparison with the use of NS. In this issue of Anesthesia & Analgesia, Choi and Brull10 have gone beyond looking at specific block-related outcomes. Rather, they evaluated meaningful outcomes as they relate to acute pain. Specifically, they provide us with a comprehensive review of the literature as it stands in 2011 comparing US with NS with the focus on acute pain- and pain-related outcomes. The acute pain-related outcomes reviewed include visual analog scale scores, time to first analgesic request, sensory block duration, opioid consumption, opioid-related side effects, patient satisfaction, complications, and length of hospital stay. Overall, for each of these outcome variables, they demonstrated that the literature either favored the use of US or was equivocal. Why is robust evidence supporting the use of US over traditional nerve localization techniques for acute pain-related outcomes lacking? The answer lies in how randomized controlled trials (RCTs) are designed and what the primary outcome variable is powered to detect. Of the 23 RCTs cited by Choi and Brull, there were only 8 studies in which the primary outcome variable was an acute pain-related outcome (pain, sensory block duration, or frequency of surgical block). In the other 15 studies, the primary outcomes measured were block-related such as sensory block, onset time, performance time, number of needle passes, and local anesthetic consumption. Therefore, the majority of the RCTs have not been powered to evaluate the outcomes that Choi and Brull set out to understand. Not surprisingly, they concluded that the current data are insufficient to form any meaningful conclusions. On the contrary, the situation is different for block-related outcome variables, whereby US clearly has demonstrated a distinct advantage over traditional nerve localizations. In our own independent appraisal of the literature,11 and the appraisal of others,9 we could only identify 1 RCT in which the primary outcome variable was powered to detect a difference in the quality of a surgical block (the conversion of a failed regional anesthetic to a general anesthetic).12 Future studies should be appropriately designed and powered to answer meaningful acute pain-related outcomes as well as block-related outcomes such as the conversion of regional anesthesia to general anesthesia. We strongly believe that trying to evaluate US versus NS as it pertains to acute pain outcomes is fraught with inefficiencies and methodological flaws that do not justify the costs of performing such clinical research. The emphasis should remain on block-related outcomes such as performance time, patient tolerance, sensory block, and the quality of a surgical block. US is not a drug being added to a local anesthetic technique, but merely a guidance technology. Significant postoperative benefits, whether long-term or short-term, from a documented complete surgical block performed either by US or NS should be identical. Furthermore, even if there were subtle differences, no clinical trial would have sufficient power to tease them out. In fact, our research community has not even been able to definitively “prove” that regional anesthesia adds long-term survival advantage over general anesthesia. For instance, Wu and Fleisher13 described that, given the inherent safety of general anesthesia, 24,000 patients would be needed per group to demonstrate a dramatic reduction in mortality by 50%. As the research investigation of what constitutes the best nerve localization technique continues, we must appreciate that, regardless of the nerve localization techniques, regional anesthesia offers numerous benefits to patients. Modern-day outcomes positively influenced by the application of regional anesthesia include, but are not limited to, improved postoperative analgesia, reductions in opioid consumption, reductions in nausea and vomiting, reductions in postoperative ileus formation, reductions in urinary retention, facilitation of hospital discharge, and improved patient satisfaction.14,15 Long-term outcomes that may be positively influenced by regional anesthesia include the reduction in chronic pain syndromes and the prevention of cancer recurrence.16,17 Therefore, the question should not be “is US better?” but, rather, Can US improve meaningful perioperative outcomes by increasing the application of regional anesthesia? If we accept the notion of equivalence between UGRA and traditional NS techniques, we would argue that equivalence is actually a victory for US. US has rejuvenated regional anesthesia, objectified much of the art, and recruited a new generation of practitioners serving to expand the practice of regional anesthesia. Thus, if peripheral regional anesthesia is now being offered where once it was not, and with a quality equivalent to experts publishing their nerve stimulator data, then the community as a whole has won. Patients will now be able to reap the benefits of regional anesthesia that we all hold as sacrosanct. Given the popular expansion of UGRA in recent years and our own anecdotal experience, it is our contention that regional anesthesia is now practiced by individuals who originally rejected regional techniques when they were based on anatomical assumptions without image guidance. In the process of expanding our regional anesthesia services, it will be incumbent on our community to contribute to large multicenter clinical registries designed to analyze and assess the impact of our practices and beliefs. These databases, such as the American Quality Institute (AQI) project,18 will hopefully address the big-ticket items that clinical trials simply cannot. In conclusion, it appears that the US revolution is here to stay. Depending on the outcome studied, this technology has proven to be either advantageous or equivocal to traditional NS techniques. At no time has it been proven to be inferior. Future RCTs should be adequately designed and powered to detect possible differences in surgical block success as a conservative measure of an intact block. The acute pain management outcomes that Choi and Brull have laid out should be studied as a regional anesthetic phenomenon, rather than a function of the nerve localization technique. At the same time, we should be mindful of the benefits of regional anesthesia and should focus on expanding the application of regional anesthesia. Given the wide popularity of UGRA, we are confident that US will continue to expand the application of regional anesthesia, allowing clinical benefits to be realized by a maximum number of patients. DISCLOSURES Name: John Antonakakis, MD. Contribution: This author helped write the manuscript. Attestation: John Antonakakis approved the final manuscript. Conflicts of Interest: John Antonakakis reported no conflicts of interest. Name: Brian Sites, MD. Contribution: This author helped write the manuscript. Attestation: Brian Sites approved the final manuscript. Conflicts of Interest: Brian Sites consults for Philips Medical Systems. This manuscript was handled by: Spencer S. Liu, MD.
No takes yet. Share an insight, caveat, or question.
Antonakakis et al. (2011) conducted an editorial in Regional anesthesia. Ultrasound-guided regional anesthesia vs. Nerve stimulation was evaluated. Ultrasound-guided regional anesthesia is advantageous or equivocal compared to traditional nerve stimulation techniques, but has never been proven inferior.
Synapse has enriched 10 related papers. Consider them for comparative context: